Vibliome Therapeutics, LLC, has developed a novel systematic approach that enables the design of small molecule kinase inhibitors with unique selectivity profiles and extraordinary selectivity. 

Pharmaceutical

Vibliome Therapeutics

Vibliome Therapeutics' headquarters in Bozeman, MT, United States

Patrick Green

Keith Flaherty

Ken Westover

Jason Fuller

Cameron Wheeler

Kwok-Kin Wong

Eric Springman

The Scientific Team at Vibliome Therapeutics is responsible for advancing the design and development of selective small molecule kinase inhibitors. This team provides expert guidance on scientific strategies, oversees medicinal chemistry efforts, and manages research alliances to ensure the creation of innovative therapeutic solutions.

Scientific Team

The Leadership Team at Vibliome Therapeutics drives the strategic vision and operational excellence of the company. Comprising the Co-founder, CEO, and VP of Medicinal Chemistry, the team oversees the development of innovative small molecule kinase inhibitors, ensuring alignment between research initiatives and business objectives to enhance drug discovery and foster growth in the therapeutic landscape.

Vibliome Therapeutics

Org chart

Board & advisors

Teams

Scientific Team

Leadership Team

Offices

Vibliome Therapeutics

Org chart

Board & advisors

Teams

Scientific Team

Leadership Team

Offices

Related companies